Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
David Calhoun enjoyed a 45% jump from 2022, but the aerospace giant has started to tie executive pay to broader safety goals.
Ford wants to charge EVs when renewables are ripe, according to its latest patent.
A GLP-1 medication from French drugmaker Sanofi — similar to Ozempic — was found to slow Parkinson’s in a small mid-stage trial.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Starting this summer, DoorDash will contribute to savings accounts for its delivery couriers in Pennsylvania.
Chase Bank announced a new advertising unit that will use customer transaction data to target them with ads.
Bob Iger is emerging victorious in Disney’s epic board seat battle with infamous activist investor Nelson Peltz.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Demand for senior living facilities is inching back toward pre-pandemic levels. But how that demand will be met is still an open question.
In the wake of the bridge collapse disaster in Baltimore, other cities are wondering if it could happen to them.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.